These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35341249)

  • 1. Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery.
    Trinh DN; Gardner RA; Franciosi AN; McCarthy C; Keane MP; Soliman MG; O'Donnell JS; Meleady P; Spencer DIR; Monopoli MP
    ACS Nano; 2022 Apr; 16(4):5463-5475. PubMed ID: 35341249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona.
    Hadjidemetriou M; Al-Ahmady Z; Buggio M; Swift J; Kostarelos K
    Biomaterials; 2019 Jan; 188():118-129. PubMed ID: 30343255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Nanomedicine Development Based on Specific Opsonization of Human Cancer Patient-Personalized Protein Coronas.
    Ren J; Cai R; Wang J; Daniyal M; Baimanov D; Liu Y; Yin D; Liu Y; Miao Q; Zhao Y; Chen C
    Nano Lett; 2019 Jul; 19(7):4692-4701. PubMed ID: 31244235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the glycans accessibility in the nanoparticle biomolecular corona.
    Clemente E; Martinez-Moro M; Trinh DN; Soliman MG; Spencer DIR; Gardner RA; Kotsias M; Sánchez Iglesias A; Moya S; Monopoli MP
    J Colloid Interface Sci; 2022 May; 613():563-574. PubMed ID: 35066229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle protein corona evolution: from biological impact to biomarker discovery.
    Kamaly N; Farokhzad OC; Corbo C
    Nanoscale; 2022 Feb; 14(5):1606-1620. PubMed ID: 35076049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.
    Wan S; Kelly PM; Mahon E; Stöckmann H; Rudd PM; Caruso F; Dawson KA; Yan Y; Monopoli MP
    ACS Nano; 2015 Feb; 9(2):2157-66. PubMed ID: 25599105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-Protein Interaction: The Significance and Role of Protein Corona.
    Ahsan SM; Rao CM; Ahmad MF
    Adv Exp Med Biol; 2018; 1048():175-198. PubMed ID: 29453539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities.
    Salvati A
    Curr Opin Biotechnol; 2024 Jun; 87():103101. PubMed ID: 38461749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Modification of Spider Silk Particles to Direct Biomolecular Corona Formation.
    Weiss ACG; Herold HM; Lentz S; Faria M; Besford QA; Ang CS; Caruso F; Scheibel T
    ACS Appl Mater Interfaces; 2020 Jun; 12(22):24635-24643. PubMed ID: 32369330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood.
    Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ
    ACS Nano; 2020 Nov; 14(11):15723-15737. PubMed ID: 33112593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-tethered glycosylated gold nanoparticles recruit sialylated glycoproteins into their protein corona, leading to off-target lectin binding.
    Ahmad A; Georgiou PG; Pancaro A; Hasan M; Nelissen I; Gibson MI
    Nanoscale; 2022 Sep; 14(36):13261-13273. PubMed ID: 36053227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System.
    Barbero F; Russo L; Vitali M; Piella J; Salvo I; Borrajo ML; Busquets-Fité M; Grandori R; Bastús NG; Casals E; Puntes V
    Semin Immunol; 2017 Dec; 34():52-60. PubMed ID: 29066063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages.
    Shaw CA; Mortimer GM; Deng ZJ; Carter ES; Connell SP; Miller MR; Duffin R; Newby DE; Hadoke PW; Minchin RF
    Nanotoxicology; 2016 Sep; 10(7):981-91. PubMed ID: 27027807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nanoparticle mechanical property on protein corona formation.
    Tengjisi ; Hui Y; Fan Y; Zou D; Talbo GH; Yang G; Zhao CX
    J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1737-1744. PubMed ID: 34507167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nanoparticle protein corona formed in human blood or human blood fractions.
    Lundqvist M; Augustsson C; Lilja M; Lundkvist K; Dahlbäck B; Linse S; Cedervall T
    PLoS One; 2017; 12(4):e0175871. PubMed ID: 28414772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid.
    Kumar A; Bicer EM; Morgan AB; Pfeffer PE; Monopoli M; Dawson KA; Eriksson J; Edwards K; Lynham S; Arno M; Behndig AF; Blomberg A; Somers G; Hassall D; Dailey LA; Forbes B; Mudway IS
    Nanomedicine; 2016 May; 12(4):1033-1043. PubMed ID: 26767511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation.
    Papafilippou L; Claxton A; Dark P; Kostarelos K; Hadjidemetriou M
    Nanoscale; 2020 May; 12(18):10240-10253. PubMed ID: 32356537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19.
    Xie Y; Butler M
    Glycobiology; 2022 Sep; 32(10):871-885. PubMed ID: 35925863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.